Patterns of antibiotic consumption in Iran during 2000-2009

International Journal of Antimicrobial Agents

Volumn 37, Issue 5, 2011, Pages 489-490

  Abdollahiasl, Akbar ^a   Kebriaeezadeh, Abbas ^a,b   Nikfar, Shekoufeh ^a,c   Farshchi, Amir ^a   Ghiasi, Golbarg ^a   Abdollahi, Mohammad ^b  

^a TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c MINISTRY OF HEALTH AND MEDICAL EDUCATION   (Iran)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOGLYCOSIDE DERIVATIVE; AMOXICILLIN; AMOXICILLIN PLUS CLAVULANIC ACID; ANTIBIOTIC AGENT; ANTIINFECTIVE AGENT; AZITHROMYCIN; CEFALEXIN; CEFIXIME; CEFTRIAXONE; CEPHALOSPORIN DERIVATIVE; CHLORAMPHENICOL DERIVATIVE; CIPROFLOXACIN; CLARITHROMYCIN; ERYTHROMYCIN; MACROLIDE; PENICILLIN DERIVATIVE; QUINOLINE DERIVED ANTIINFECTIVE AGENT; TETRACYCLINE DERIVATIVE;

DRUG CLASSIFICATION; DRUG COST; DRUG MARKETING; DRUG USE; EUROPEAN UNION; HEALTH CARE SYSTEM; HEALTH INSURANCE; IRAN; LETTER; PHARMACY; PRESCRIPTION; PRIORITY JOURNAL;

ANTI-BACTERIAL AGENTS; DRUG UTILIZATION; HUMANS; IRAN;

EID: 79953853302     PISSN: 09248579     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijantimicag.2011.01.022     Document Type: Letter

References (7)

1. Statistical Center of Iran. http://www.amar.org.ir [accessed 13 December 2010].
2. Okeke IN, Laxminarayan R, Bhutta ZA, Duse AG, Jenkins P, O'Brien TF, et al. Antimicrobial resistance in developing countries, Part I: recent trends and current status. Lancet Infect Dis 2005;5:481-93.
3. Karabay O, Hosoglu S. Increased antimicrobial consumption following reimbursement reform in Turkey. J Antimicrob Chemother 2008;61:1169-71. (Pubitemid 351524466)
4. Hutchinson JM, Patrick DM, Marra F, Ng H, Bowie WR, Heule L, et al. Measurement of antibiotic consumption: a practical guide to the use of the Anatomical Therapeutic Chemical classification and Defined Daily Dose system methodology in Canada. Can J Infect Dis 2004;15:29-35. (Pubitemid 38387655)
5. Zargarzadeh AH, Minaeiyan M, Torabi A. Prescription and nonprescription drug use in Isfahan, Iran: an observational, cross-sectional study. Current Ther Res 2008;69:76-87. (Pubitemid 351446017)
6. Coenen S, Muller A, Adriaenssens N, Vankerckhoven V, Hendrickx E, Goossens H, et al. European Surveillance of Antimicrobial Consumption (ESAC): out-patient parenteral antibiotic treatment in Europe. J Antimicrob Chemother 2009;64:200-5.
7. Nikfar S, Kebriaeezadeh A, Majdzadeh R, Abdollahi M. Monitoring of National Drug Policy (NDP) and its standardized indicators; conformity to decisions of the National Drug Selecting Committee in Iran. BMC Int Health Hum Rights 2005;5:5.